Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 109

1.

Epstein - Barr virus transforming protein LMP-1 alters B cells gene expression by promoting accumulation of the oncoprotein ΔNp73α.

Accardi R, Fathallah I, Gruffat H, Mariggiò G, Le Calvez-Kelm F, Voegele C, Bartosch B, Hernandez-Vargas H, McKay J, Sylla BS, Manet E, Tommasino M.

PLoS Pathog. 2013 Mar;9(3):e1003186. doi: 10.1371/journal.ppat.1003186. Epub 2013 Mar 14.

2.

Oncoprotein E7 from beta human papillomavirus 38 induces formation of an inhibitory complex for a subset of p53-regulated promoters.

Saidj D, Cros MP, Hernandez-Vargas H, Guarino F, Sylla BS, Tommasino M, Accardi R.

J Virol. 2013 Nov;87(22):12139-50. doi: 10.1128/JVI.01047-13. Epub 2013 Sep 4.

3.
4.

Latent membrane protein 1 of Epstein-Barr virus plays an important role in the serum starvation resistance of Epstein-Barr virus-immortalized B lymphocytes.

Park CH, Kim HR, Kim J, Jang SH, Lee KY, Chung GH, Jang YS.

J Cell Biochem. 2004 Mar 1;91(4):777-85.

PMID:
14991769
5.

Epstein-Barr virus latent membrane protein-1 triggers AP-1 activity via the c-Jun N-terminal kinase cascade.

Kieser A, Kilger E, Gires O, Ueffing M, Kolch W, Hammerschmidt W.

EMBO J. 1997 Nov 3;16(21):6478-85.

6.

Epstein-Barr virus nuclear antigen 3C interact with p73: Interplay between a viral oncoprotein and cellular tumor suppressor.

Sahu SK, Mohanty S, Kumar A, Kundu CN, Verma SC, Choudhuri T.

Virology. 2014 Jan 5;448:333-43. doi: 10.1016/j.virol.2013.10.023. Epub 2013 Nov 12.

7.

IkappaB kinase beta promotes cell survival by antagonizing p53 functions through DeltaNp73alpha phosphorylation and stabilization.

Accardi R, Scalise M, Gheit T, Hussain I, Yue J, Carreira C, Collino A, Indiveri C, Gissmann L, Sylla BS, Tommasino M.

Mol Cell Biol. 2011 Jun;31(11):2210-26. doi: 10.1128/MCB.00964-10. Epub 2011 Apr 11.

8.

Functional analysis of the mutated Epstein-Barr virus oncoprotein LMP1(69del): implications for a new role of naturally occurring LMP1 variants.

Larcher C, Bernhard D, Schaadt E, Adler B, Ausserlechner MJ, Mitterer M, Huemer HP.

Haematologica. 2003 Dec;88(12):1324-35.

9.

Epstein-Barr virus down-regulates tumor suppressor DOK1 expression.

Siouda M, Frecha C, Accardi R, Yue J, Cuenin C, Gruffat H, Manet E, Herceg Z, Sylla BS, Tommasino M.

PLoS Pathog. 2014 May 8;10(5):e1004125. doi: 10.1371/journal.ppat.1004125. eCollection 2014 May.

10.

The neurogene BTG2TIS21/PC3 is transactivated by DeltaNp73alpha via p53 specifically in neuroblastoma cells.

Goldschneider D, Million K, Meiller A, Haddada H, Puisieux A, Bénard J, May E, Douc-Rasy S.

J Cell Sci. 2005 Mar 15;118(Pt 6):1245-53. Epub 2005 Mar 1.

11.

A single amino acid in EBNA-2 determines superior B lymphoblastoid cell line growth maintenance by Epstein-Barr virus type 1 EBNA-2.

Tzellos S, Correia PB, Karstegl CE, Cancian L, Cano-Flanagan J, McClellan MJ, West MJ, Farrell PJ.

J Virol. 2014 Aug;88(16):8743-53. doi: 10.1128/JVI.01000-14. Epub 2014 May 21.

13.

C-terminal region of EBNA-2 determines the superior transforming ability of type 1 Epstein-Barr virus by enhanced gene regulation of LMP-1 and CXCR7.

Cancian L, Bosshard R, Lucchesi W, Karstegl CE, Farrell PJ.

PLoS Pathog. 2011 Jul;7(7):e1002164. doi: 10.1371/journal.ppat.1002164. Epub 2011 Jul 28.

14.
15.
16.

Oxidative stress enables Epstein-Barr virus-induced B-cell transformation by posttranscriptional regulation of viral and cellular growth-promoting factors.

Chen X, Kamranvar SA, Masucci MG.

Oncogene. 2016 Jul 21;35(29):3807-16. doi: 10.1038/onc.2015.450. Epub 2015 Nov 23.

PMID:
26592445
17.
18.

Identification of a promoter for the latent membrane protein 1 gene of Epstein-Barr virus that is specifically activated in human epithelial cells.

Chang MH, Ng CK, Lin YJ, Liang CL, Chung PJ, ChenML, Tyan YS, Hsu CY, Shu CH, Chang YS.

DNA Cell Biol. 1997 Jul;16(7):829-37.

PMID:
9260926
19.

Down-regulation of BLIMP1α by the EBV oncogene, LMP-1, disrupts the plasma cell differentiation program and prevents viral replication in B cells: implications for the pathogenesis of EBV-associated B-cell lymphomas.

Vrzalikova K, Vockerodt M, Leonard S, Bell A, Wei W, Schrader A, Wright KL, Kube D, Rowe M, Woodman CB, Murray PG.

Blood. 2011 Jun 2;117(22):5907-17. doi: 10.1182/blood-2010-09-307710. Epub 2011 Mar 16.

20.

EBV latency III immortalization program sensitizes B cells to induction of CD95-mediated apoptosis via LMP1: role of NF-kappaB, STAT1, and p53.

Le Clorennec C, Youlyouz-Marfak I, Adriaenssens E, Coll J, Bornkamm GW, Feuillard J.

Blood. 2006 Mar 1;107(5):2070-8. Epub 2005 Nov 29.

Supplemental Content

Support Center